Suchergebnisse - "Hanscom, Brett"

PubPharm (112)

1

Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs : the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)

enthalten in: Trials | 2024

von Goodman-Meza, D. | Shoptaw, S. | Hanscom, B. | +14

2

Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)

enthalten in: Trials | 2024

von Goodman-Meza, D. | Shoptaw, S. | Hanscom, B. | +13

3

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding : a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Landovitz, R. | Hanscom, B. | Clement, M. | +28

CommentIn: Lancet HIV. 2023 Dec;10(12):e756-e757. - PMID 37952552

4

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women : a secondary analysis of the HPTN 083 trial

enthalten in: The lancet. HIV | 2023

von Marzinke, M. | Hanscom, B. | Wang, Z. | +71

CommentIn: Lancet HIV. 2023 Nov;10(11):e694-e695. - PMID 37783220

5

Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults : a phase 1 randomised trial

enthalten in: The lancet. HIV | 2023

von Sobieszczyk, M. | Mannheimer, S. | Paez, C. | +25

CommentIn: Lancet HIV. 2023 Oct;10(10):e625-e626. - PMID 37802563

6

Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings : a model comparison analysis

enthalten in: Journal of the International AIDS Society | 2023

von Stansfield, S. | Heitner, J. | Mitchell, K. | +12

7

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data : example of injectable cabotegravir and oral PrEP in women

enthalten in: Journal of the International AIDS Society | 2023

von Donnell, D. | Gao, F. | Hughes, J. | +11

8

Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam : findings from HPTN 074 randomized trial

enthalten in: BMC infectious diseases | 2023

von Dumchev, K. | Guo, X. | Ha, T. | +13

9

Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial

enthalten in: BMC infectious diseases | 2023

von Dumchev, K. | Guo, X. | Ha, T. | +13

10

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention : HPTN 083

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Marzinke, M. | Fogel, J. | Wang, Z. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]